Medi-Tech Insights Get in touch

Global Nuclear Medicine Market Size & Trends Report Segmented by Product (SPECT, PET, Alpha & Beta Emitters, Brachytherapy), Application (Cardiology, Neurology, Oncology, Urology, Thyroid, Lymphoma, Bone Metastasis), End-user (Hospitals, Diagnostic Centers) & Regional Forecasts to 2031

Request Quote Download FREE Sample
Single User

Table of Contents

  1. Introduction
    • Introduction
    • Market Scope
      • Market Definition
      • Segments Covered
      • Regional Segmentation
    • Research Timeframe
    • Currency Considered
    • Study Limitations
    • Stakeholders
    • List of Abbreviations
    • Key Conferences and Events (2026-2027)
  2. Research Methodology
    • Secondary Research
    • Primary Research
    • Market Estimation
      • Bottom-Up Approach
      • Top-Down Approach
    • Market Forecasting
  3. Executive Summary
    • Nuclear Medicine Marke
    • Market Overview
      • Market Dynamics
        • Drivers
          • Increasing incidence of chronic diseases
          • Rising demand for early and accurate diagnostic solutions in healthcare
          • Growing preference for non-invasive diagnostic and therapeutic techniques
          • Increasing adoption of hybrid imaging systems
          • Expanding applications in personalized medicine and neurology
        • Restraints
          • High cost of nuclear imaging equipment and radiopharmaceuticals
          • Stringent regulatory requirements for approval of isotopes and procedures
          • Limited availability and short half-life of radioisotopes
        • Opportunities
          • Development of next-generation radiopharmaceuticals for emerging therapeutic applications
          • Miniaturization of imaging systems for portable and cost-effective solutions
          • Growing government investments and support for nuclear medicine research
        • Key Mar
        • Integration of AI in nuclear imaging for enhanced precision and efficiency
        • Introduction of novel isotopes like Actinium-225 and Lutetium-177 for targeted therapies
      • Unmet Market Needs
      • Industry Speaks
  4. Global Nuclear Medicine Market Size & Forecast (2024-2031), By Product, USD Billion
    • Introduction
    • Diagnostics
      • SPECT
        • TC-99m
        • TL-201
        • GA-67
        • I-123
        • Others
      • PET
        • F-18
        • SR-82/RB-82
        • PYLARIFY (piflufolastat F 18)
        • Illuccix (gallium Ga 68 gozetotide)
        • Others
      • Therapeutics
        • Alpha Emitters
          • RA-223
          • Others
        • Beta Emitters
          • I-131
          • Y-90
          • SM-153
          • Re-186
          • Lu-177
          • Others
        • Brachytherapy
          • Cesium-131
          • Iodine-125
          • Palladium-103
          • Iridium-192
          • Others
  • Global Nuclear Medicine Market Size & Forecast (2024-2031), By Application, USD Billion
    • Introduction
    • Cardiology
    • Neurology
    • Oncology
    • Thyroid
    • Lymphoma
    • Bone Metastasis
    • Endocrine Tumour
    • Pulmonary Scans
    • Urology
    • Other Applications
  • Global Nuclear Medicine Market Size & Forecast (2024-2031), By End User, USD Billion
    • Introduction
    • Hospitals
    • Diagnostic Centers
    • Other End Users
    1. Global Nuclear Medicine Market Size & Forecast (2024-2031), By Region, USD Billion
      • Introduction
      • North America Nuclear Medicine Market Size & Forecast (2024-2031), By Country, USD Billion
        • US
          • Market Size & Forecast, By Product (USD Billion)
          • Market Size & Forecast, By Application (USD Billion)
          • Market Size & Forecast, By End User (USD Billion)
        • Canada
          • Market Size & Forecast, By Product (USD Billion)
          • Market Size & Forecast, By Application (USD Billion)
          • Market Size & Forecast, By End User (USD Billion)
      • Europe Nuclear Medicine Market Size & Forecast (2024-2031), By Country, USD Billion
        • UK
          • Market Size & Forecast, By Product (USD Billion)
          • Market Size & Forecast, By Application (USD Billion)
          • Market li>
        • Germany
          • Market Size & Forecast, By Product (USD Billion)
          • Market Size & Forecast, By Application (USD Billion)
          • Market Size & Forecast, By End User (USD Billion)
        • France
          • Market Size & Forecast, By Product (USD Billion)
          • Market Size & Forecast, By Application (USD Billion)
          • Market Size & Forecast, By End User (USD Billion)
        • Italy
          • Market Size & Forecast, By Product (USD Billion)
          • Market Size & Forecast, By Application (USD Billion)
          • Market Size & Forecast, By End User (USD Billion)
        • Spain
          • Market Size & Forecast, By Product (USD Billion)
          • Market Size & Forecast, By Application (USD Billion)
          • Market Size & Forecast, By End User (USD Billion)
        • Rest of Europe
          • Market Size & Forecast, By Product (USD Billion)
          • Market Size & Forecast, By End User (USD Billion)
      • Asia Pacific (APAC) Nuclear Medicine Market Size & Forecast (2024-2031), By Country, USD Billion
        • China
          • Market Size & Forecast, By Product (USD Billion)
          • Market Size & Forecast, By Application (USD Billion)
          • Market Size & Forecast, By End User (USD Billion)
        • Japan
          • Market Size & Forecast, By Product (USD Billion)
          • Market Size & Forecast, By Application (USD Billion)
          • Market Size & Forecast, By End User (USD Billion)
        • India
          • Market Size & Forecast, By Product (USD Billion)
          • Market Size & Forecast, By Application (USD Billion)
          • Market Size & Forecast, By End User (USD Billion)
        • Rest of Asia Pacific
          • Market Size & Forecast, By Product (USD Billion)
          • Market Size & Forecast, By End User (USD Billion)
      • Latin America (LATAM) Nuclear Medicine Market Size & Forecast (2024-2031), USD Billion
        • Market Size & Forecast, By Product (USD Billion)
        • Market Size & Forecast, By Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • Middle East & Africa (MEA) Nuclear Medicine Market Size & Forecast (2024-2031), USD Billion
        • Market Size & Forecast, By Product (USD Billion)
        • Market Size & Forecast, By Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)

    2. Competitive Landscape
      • Key Players and their Competitive Positioning
        • Key Player Comparison
        • Segment-wise Player Mapping
        • Market Share Analysis (2025)
        • Company Categorization Matrix
          • Dominants/Leaders
          • New Entrants
          • Emerging Players
          • Innovative Players
        • Key Strategies Assessment, By Player (2023-2026)
          • New Product Launch/Approval
          • Partnerships, Agreements, & Collaborations
          • Mergers & Acquisitions
          • Geographic Expansion
    1. Company Profiles*

    (Business Overview, Financial Performance**, Products Offered, Recent Developments)

    • GE HealthCare
    • Curium Pharma
    • Lantheus Holdings, Inc.
    • Cardinal Health, Inc.
    • Bracco Imaging S.p.A.
    • Jubilant Pharmova Limited
    • The Australian Nuclear Science and Technology Organization (ANSTO)
    • Nordion (Canada) Inc.
    • Eckert & Ziegler SE
    • Institute for Radioelements (IRE)
    • Other Prominent Players

    Note: *Indicative list

    **For listed companies

    Related Reports

    View All Research Reports